Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Use of L-asparaginase in childhood ALL.

Müller HJ, Boos J.

Crit Rev Oncol Hematol. 1998 Aug;28(2):97-113. Review.

PMID:
9768345
3.

Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.

Piatkowska-Jakubas B, Krawczyk-Kuliś M, Giebel S, Adamczyk-Cioch M, Czyz A, Lech Marańda E, Paluszewska M, Pałynyczko G, Piszcz J, Hołowiecki J; Polish Adult Leukemia Group.

Pol Arch Med Wewn. 2008 Nov;118(11):664-9. Review.

4.

PEG-asparaginase.

Fu CH, Sakamoto KM.

Expert Opin Pharmacother. 2007 Aug;8(12):1977-84. Review.

PMID:
17696798
5.
7.

[Significance of L-asparaginase activity and biochemical parameters evaluation in children with acute lymphoblastic leukemia].

Pawińska K, Balwierz W, Sztefko K, Czogała M.

Przegl Lek. 2006;63(1):44-6. Review. Polish.

PMID:
16892900
8.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
9.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
10.

L-asparaginase: a promising chemotherapeutic agent.

Verma N, Kumar K, Kaur G, Anand S.

Crit Rev Biotechnol. 2007 Jan-Mar;27(1):45-62. Review.

PMID:
17364689
11.

Pegaspargase: an alternative?

Holle LM.

Ann Pharmacother. 1997 May;31(5):616-24. Review.

PMID:
9161659
12.
13.

Optimizing asparaginase therapy for acute lymphoblastic leukemia.

Rizzari C, Conter V, Starý J, Colombini A, Moericke A, Schrappe M.

Curr Opin Oncol. 2013 Mar;25 Suppl 1:S1-9. doi: 10.1097/CCO.0b013e32835d7d85. Review.

PMID:
23380829
14.

Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia.

Narta UK, Kanwar SS, Azmi W.

Crit Rev Oncol Hematol. 2007 Mar;61(3):208-21. Epub 2006 Oct 2. Review.

PMID:
17011787
15.

Pegaspargase: a review of clinical studies.

Graham ML.

Adv Drug Deliv Rev. 2003 Sep 26;55(10):1293-302. Review.

PMID:
14499708
16.

Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?

Douer D.

Best Pract Res Clin Haematol. 2008 Dec;21(4):647-58. doi: 10.1016/j.beha.2008.08.004. Review.

PMID:
19041604
17.

Asparaginase revisited.

van den Berg H.

Leuk Lymphoma. 2011 Feb;52(2):168-78. doi: 10.3109/10428194.2010.537796. Review.

PMID:
21281233
18.

Asparaginase in the treatment of non-ALL hematologic malignancies.

Emadi A, Zokaee H, Sausville EA.

Cancer Chemother Pharmacol. 2014 May;73(5):875-83. doi: 10.1007/s00280-014-2402-3. Epub 2014 Feb 11. Review.

PMID:
24515335
19.

Tolerability and efficacy of L-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia.

Raetz EA, Salzer WL.

J Pediatr Hematol Oncol. 2010 Oct;32(7):554-63. doi: 10.1097/MPH.0b013e3181e6f003. Review.

PMID:
20724951
20.

[Update on L-asparaginase treatment in paediatrics].

Moscardó Guilleme C, Fernández Delgado R, Sevilla Navarro J, Astigarraga Aguirre I, Rives Solà S, Sánchez de Toledo Codina J, Fuster Soler JL, Parra Ramirez L, Molina Garicaño J, González Martínez B, Madero López L.

An Pediatr (Barc). 2013 Nov;79(5):329.e1-329.e11. doi: 10.1016/j.anpedi.2013.03.015. Epub 2013 May 31. Review. Spanish.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk